Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    8980179 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed BAY 43-9006 (Sorafenib) to Treat Patients With Kaposi's Sarcoma
Conditions: Kaposi's Sarcoma;   HHV-8;   KSHV
Intervention: Drug: BAY 43-9006

Study has passed its completion date and status has not been verified in more than two years.